Hainan Shuangcheng Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 73.23 million compared to CNY 83.76 million a year ago. Revenue was CNY 73.23 million compared to CNY 83.76 million a year ago.

Net income was CNY 0.730119 million compared to net loss of CNY 3.38 million a year ago. Basic earnings per share from continuing operations was CNY 0.0018 compared to basic loss per share from continuing operations of CNY 0.01 a year ago. Diluted earnings per share from continuing operations was CNY 0.0018 compared to diluted loss per share from continuing operations of CNY 0.01 a year ago.